Apyx Medical (APYX) Gross Profit (2011 - 2026)

Apyx Medical (APYX) has reported Gross Profit for 16 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 25.23% year-over-year to $8.9 million; the trailing twelve-month figure through Jun 2026 stood at $37.1 million (up 29.39% YoY), and the FY2025 full-year result was $33.0 million, up 12.55% from the prior year.
• Gross Profit rose to $8.9 million in Q2 2026 per APYX's latest filing, from $7.9 million in the prior quarter.
• Across five years, Gross Profit topped out at $12.0 million in Q4 2025 and bottomed at $5.7 million in Q1 2025.
• Historically, Gross Profit has averaged $7.9 million across 5 years, with a median of $8.0 million in 2023.
• The widest YoY moves for Gross Profit: up 40.26% in 2022, down 32.18% in 2022.
• Over 5 years, Gross Profit stood at $8.2 million in 2022, then grew by 8.35% to $8.9 million in 2023, then grew by 0.39% to $9.0 million in 2024, then jumped by 33.86% to $12.0 million in 2025, then retreated by 26.08% to $8.9 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $8.9 million, $7.9 million, and $12.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.